Lymphoma

Treating Aggressive NHL

Video

Monoclonal antibodies are improving treatment success for many people with aggressive forms of non-Hodgkin's lymphoma. How do they work?

Video	-	Monoclonal Antibodies in Aggressive NHL Transcript
Video	-	Targeted Therapy for NHL Transcript
Video	-	Treating Recurrent NHL with Monoclonal Antibodies Transcript
Video	-	Treating Follicular Non-Hodgkin's Lymphoma Transcript
Video	-	Attacking NHL Early Transcript
Ask Your Doctor	-	About Molecular-Targeted Therapies
Video	-	How To Choose the Best Treatment Option When Indolent NHL Returns Transcript
Video	-	Treatment Options in Relapsed, Indolent Non-Hodgkin's Lymphoma Transcript
Video	-	Starting Targeted Therapy For Lymphoma: What Are The Options? Transcript
Video	-	Radioimmunotherapy for Non-Hodgkin's Lymphoma Transcript
Video	-	Radioimmunotherapy: Safety Measures During Therapy Transcript
Video	-	A New Way to Attack NHL Transcript
Video	-	New Weapons in the War on Cancer: Monoclonal Antibodies Transcript
Video	-	Expanding the Use of Rituxan in NHL Treatment Transcript
Video	-	Rituxan: Not Just for Cancer? Transcript
Video	-	Measuring Success with Targeted Therapy for NHL Transcript
Video	-	Testing Vaccines for Non-Hodgkin's Lymphoma Transcript
Video	-	Treating Lymphoma: Will a Customized Vaccine Work? Transcript
Article	-	Bone Marrow Transplantation for Non-Hodgkin's Lymphoma
Article	-	Falling Short: Under-Treatment in Non-Hodgkin's Lymphoma

How confident are you that the Food and Drug Administration makes sure prescription drugs are safe?

	Very confident		Somewhat confident
	Not confident at all		No opinion about it